Home LiteratureArticle Details
PMID: 21471965 Published · ppublish English Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Suppression of lung adenocarcinoma progression by Nkx2-1.

Nature ·Vol. 473 ·No. 7345 ·2011-05-05 ·Pages 101-4

Winslow MM, Dayton TL, Verhaak RG, Kim-Kiselak C, Snyder EL, Feldser DM, Hubbard DD, DuPage MJ, Whittaker CA, Hoersch S, Yoon S, Crowley D, Bronson RT, Chiang DY, Meyerson M, Jacks T

Abstract

Despite the high prevalence and poor outcome of patients with metastatic lung cancer the mechanisms of tumour progression and metastasis remain largely uncharacterized. Here we modelled human lung adenocarcinoma, which frequently harbours activating point mutations in KRAS and inactivation of the p53 pathway, using conditional alleles in mice. Lentiviral-mediated somatic activation of oncogenic Kras and deletion of p53 in the lung epithelial cells of Kras(LSL-G12D/+);p53(flox/flox) mice initiates lung adenocarcinoma development. Although tumours are initiated synchronously by defined genetic alterations, only a subset becomes malignant, indicating that disease progression requires additional alterations. Identification of the lentiviral integration sites allowed us to distinguish metastatic from non-metastatic tumours and determine the gene expression alterations that distinguish these tumour types. Cross-species analysis identified the NK2-related homeobox transcription factor Nkx2-1 (also called Ttf-1 or Titf1) as a candidate suppressor of malignant progression. In this mouse model, Nkx2-1 negativity is pathognomonic of high-grade poorly differentiated tumours. Gain- and loss-of-function experiments in cells derived from metastatic and non-metastatic tumours demonstrated that Nkx2-1 controls tumour differentiation and limits metastatic potential in vivo. Interrogation of Nkx2-1-regulated genes, analysis of tumours at defined developmental stages, and functional complementation experiments indicate that Nkx2-1 constrains tumours in part by repressing the embryonically restricted chromatin regulator Hmga2. Whereas focal amplification of NKX2-1 in a fraction of human lung adenocarcinomas has focused attention on its oncogenic function, our data specifically link Nkx2-1 downregulation to loss of differentiation, enhanced tumour seeding ability and increased metastatic proclivity. Thus, the oncogenic and suppressive functions of Nkx2-1 in the same tumour type substantiate its role as a dual function lineage factor.

MeSH Terms
Adenocarcinoma/genetics,physiopathology Adenocarcinoma of Lung Animals Cell Differentiation Cell Line, Tumor Disease Models, Animal Down-Regulation Gene Expression Regulation, Neoplastic HMGA2 Protein/genetics Humans Lung Neoplasms/genetics,physiopathology Mice Nuclear Proteins/genetics,metabolism Thyroid Nuclear Factor 1 Transcription Factors/genetics,metabolism
Chemicals
HMGA2 Protein NKX2-1 protein, human Nkx2-1 protein, mouse Nuclear Proteins Thyroid Nuclear Factor 1 Transcription Factors
Authors & Affiliations
16 authors, click to expand affiliations / ORCID
Winslow Monte M
David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA.
Dayton Talya L
Verhaak Roel G W
Kim-Kiselak Caroline
Snyder Eric L
Feldser David M
Hubbard Diana D
DuPage Michel J
Whittaker Charles A
Hoersch Sebastian
Yoon Stephanie
Crowley Denise
Bronson Roderick T
Chiang Derek Y
Meyerson Matthew
Jacks Tyler
References (29)
29 references, click to expand
  1. let-7 regulates self renewal and tumorigenicity of breast cancer cells.
    Cell. 2007 Dec 14;131(6):1109-23 PMID: 18083101
  2. Lineage-specific dependency of lung adenocarcinomas on the lung development regulator TTF-1.
    Cancer Res. 2007 Jul 1;67(13):6007-11 PMID: 17616654
  3. The T/ebp null mouse: thyroid-specific enhancer-binding protein is essential for the organogenesis of the thyroid, lung, ventral forebrain, and pituitary.
    Genes Dev. 1996 Jan 1;10(1):60-9 PMID: 8557195
  4. Conditional mouse lung cancer models using adenoviral or lentiviral delivery of Cre recombinase.
    Nat Protoc. 2009;4(7):1064-72 PMID: 19561589
  5. HMGI-C, a member of the high mobility group family of proteins, is expressed in hematopoietic stem cells and in leukemic cells.
    Leuk Lymphoma. 1997 Aug;26(5-6):603-7 PMID: 9389367
  6. An embryonic stem cell-like gene expression signature in poorly differentiated aggressive human tumors.
    Nat Genet. 2008 May;40(5):499-507 PMID: 18443585
  7. Choreoathetosis, hypothyroidism, and pulmonary alterations due to human NKX2-1 haploinsufficiency.
    J Clin Invest. 2002 Feb;109(4):475-80 PMID: 11854319
  8. Characterizing the cancer genome in lung adenocarcinoma.
    Nature. 2007 Dec 6;450(7171):893-8 PMID: 17982442
  9. Analysis of lung tumor initiation and progression using conditional expression of oncogenic K-ras.
    Genes Dev. 2001 Dec 15;15(24):3243-8 PMID: 11751630
  10. Transcriptional control of lung morphogenesis.
    Physiol Rev. 2007 Jan;87(1):219-44 PMID: 17237346
  11. The differential effects of mutant p53 alleles on advanced murine lung cancer.
    Cancer Res. 2005 Nov 15;65(22):10280-8 PMID: 16288016
  12. Gene expression-based survival prediction in lung adenocarcinoma: a multi-site, blinded validation study.
    Nat Med. 2008 Aug;14(8):822-7 PMID: 18641660
  13. Synergistic tumor suppressor activity of BRCA2 and p53 in a conditional mouse model for breast cancer.
    Nat Genet. 2001 Dec;29(4):418-25 PMID: 11694875
  14. p53: a frequent target for genetic abnormalities in lung cancer.
    Science. 1989 Oct 27;246(4929):491-4 PMID: 2554494
  15. Genomic profiling identifies TITF1 as a lineage-specific oncogene amplified in lung cancer.
    Oncogene. 2008 Jun 5;27(25):3635-40 PMID: 18212743
  16. Hmga2 promotes neural stem cell self-renewal in young but not old mice by reducing p16Ink4a and p19Arf Expression.
    Cell. 2008 Oct 17;135(2):227-39 PMID: 18957199
  17. High-level expression of DNA architectural factor HMGA2 and its association with nucleosomes in human embryonic stem cells.
    Genesis. 2006 Nov;44(11):523-9 PMID: 17078040
  18. Clinical significance of TTF-1 protein expression and TTF-1 gene amplification in lung adenocarcinoma.
    J Cell Mol Med. 2009 Aug;13(8B):1977-1986 PMID: 19040416
  19. Thyroid transcription factor 1--a new prognostic factor in lung cancer: a meta-analysis.
    Ann Oncol. 2006 Nov;17(11):1673-6 PMID: 16980598
  20. Oncogenic cooperation and coamplification of developmental transcription factor genes in lung cancer.
    Proc Natl Acad Sci U S A. 2007 Oct 16;104(42):16663-8 PMID: 17925434
  21. Mutant p53 gain of function in two mouse models of Li-Fraumeni syndrome.
    Cell. 2004 Dec 17;119(6):847-60 PMID: 15607980
  22. The tumor suppressor microRNA let-7 represses the HMGA2 oncogene.
    Genes Dev. 2007 May 1;21(9):1025-30 PMID: 17437991
  23. Expression of HMGI-C, a member of the high mobility group protein family, in a subset of breast cancers: relationship to histologic grade.
    Mol Carcinog. 1997 Jul;19(3):153-6 PMID: 9254881
  24. WNT/TCF signaling through LEF1 and HOXB9 mediates lung adenocarcinoma metastasis.
    Cell. 2009 Jul 10;138(1):51-62 PMID: 19576624
  25. Incidence and possible clinical significance of K-ras oncogene activation in adenocarcinoma of the human lung.
    Cancer Res. 1988 Oct 15;48(20):5738-41 PMID: 3048648
  26. HMGA2 overexpression in non-small cell lung cancer.
    Mol Carcinog. 2007 Jul;46(7):503-11 PMID: 17477356
  27. Roles of HMGA proteins in cancer.
    Nat Rev Cancer. 2007 Dec;7(12):899-910 PMID: 18004397
  28. HMGA2 protein expression correlates with lymph node metastasis and increased tumor grade in pancreatic ductal adenocarcinoma.
    Mod Pathol. 2009 Jan;22(1):43-9 PMID: 18843278
  29. HMGA2 participates in transformation in human lung cancer.
    Mol Cancer Res. 2008 May;6(5):743-50 PMID: 18505920
Article Info
Journal
Nature
Abbr.
Nature
ISSN
1476-4687
Published
2011-05-05
Epub
2011-00-06
Pages
101-4
Language
English
Region
England
NLM ID
0410462
PMCID
PMC3088778
Subset
IM
Grants
NCI NIH HHS · U01 CA084306-13 · United States
NCI NIH HHS · U01 CA084306-11 · United States
NHLBI NIH HHS · T32 HL007627 · United States
NCI NIH HHS · U01 CA084306-12 · United States
NCI NIH HHS · U01 CA084306 · United States
NCI NIH HHS · P30-CA14051 · United States
NCI NIH HHS · P30 CA014051-37 · United States
NCI NIH HHS · R01 CA109038 · United States
NCI NIH HHS · U01-CA84306 · United States
NCI NIH HHS · P30 CA014051-36 · United States
NCI NIH HHS · P30 CA014051-39 · United States
NCI NIH HHS · K08 CA154784 · United States
NCI NIH HHS · P30 CA014051 · United States
NCI NIH HHS · P30 CA014051-40 · United States
NCI NIH HHS · K99 CA151968 · United States
Howard Hughes Medical Institute · United States
NCI NIH HHS · R00 CA151968 · United States
NCI NIH HHS · P30 CA014051-38 · United States
NCI NIH HHS · K99-CA151968 · United States
NHLBI NIH HHS · T32-HL007627 · United States
Databases
GEO
Corrections
CommentIn
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com